Literature DB >> 6439361

How soon after myocardial infarction should plasma lipid values be assessed?

R E Ryder, T M Hayes, I P Mulligan, J C Kingswood, S Williams, D R Owens.   

Abstract

Because acute myocardial infarction may affect plasma lipid concentrations it is commonly recommended that assessment of these concentrations should be delayed until about three months after the acute event. A study was therefore conducted of fasting plasma lipid concentrations in 58 patients with acute myocardial infarction. Measurements were made during their stay in hospital (days 1, 2, and 9) and three months later. Triglyceride concentrations remained unchanged throughout. Values of total cholesterol, low density lipoprotein, and high density lipoprotein all fell significantly between the first two days and day 9. Total cholesterol and low density lipoprotein also showed significant falls between days 1 and 2. Nevertheless, fasting plasma lipid concentrations showed no significant difference at any time during the first 48 hours from values measured three months later. After the infarction 26 patients changed to eating less fat or less energy, or both. More patients had hypercholesterolaemia in the first 48 hours than at three months. These results suggest that lipid state may be assessed as accurately, and possibly more accurately, during the first 48 hours after acute myocardial infarction than at three months.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6439361      PMCID: PMC1443809          DOI: 10.1136/bmj.289.6459.1651

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  13 in total

1.  SERUM LIPIDS DURING THE COURSE OF AN ACUTE MYOCARDIAL INFARCTION AND ONE YEAR AFTERWARDS.

Authors:  G TIBBLIN; K CRAMER
Journal:  Acta Med Scand       Date:  1963-10

2.  Influence of myocardial infarction on plasma-lipoprotein concentration.

Authors:  C DODDS; G L MILLS
Journal:  Lancet       Date:  1959-06-06       Impact factor: 79.321

3.  Cholesterol values in patients with myocardial infarction and in a normal control group.

Authors:  G BIORCK; G BLOMQVIST; J SIEVERS
Journal:  Acta Med Scand       Date:  1957-02-02

4.  Disturbances in serum lipids and in their fatty acid composition following acute myocardial infarction.

Authors:  K Kirkeby
Journal:  Acta Med Scand       Date:  1972-12

5.  Probability of middle-aged men developing coronary heart disease in five years.

Authors:  A Keys; C Aravanis; H Blackburn; F S Van Buchem; R Buzina; B S Djordjevic; F Fidanza; M J Karvonen; A Menotti; V Puddu; H L Taylor
Journal:  Circulation       Date:  1972-04       Impact factor: 29.690

6.  Managing hyperlipidaemias.

Authors:  B M Buckley; A M Bold
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-06

7.  Effect of combined clofibrate--nicotinic acid treatment in ischemic heart disease.

Authors:  G Rosenhamer; L A Carlson
Journal:  Atherosclerosis       Date:  1980-09       Impact factor: 5.162

8.  Serum lipids and lipoprotein concentrations during the acute phase of myocardial infarction.

Authors:  D Heldenberg; A Rubinstein; O Levtov; L Berns; B Werbin; I Tamir
Journal:  Atherosclerosis       Date:  1980-04       Impact factor: 5.162

9.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

10.  Contractile performance of the hypertrophied ventricle in patients with systemic hypertension.

Authors:  M Takahashi; S Sasayama; C Kawai; H Kotoura
Journal:  Circulation       Date:  1980-07       Impact factor: 29.690

View more
  27 in total

Review 1.  Pathogenesis and pathology of coronary heart disease syndromes.

Authors:  P M Ridker; E M Antman
Journal:  J Thromb Thrombolysis       Date:  1999-10       Impact factor: 2.300

Review 2.  The relationship between cholesterol and stroke: implications for antihyperlipidaemic therapy in older patients.

Authors:  C Sarti; M Kaarisalo; J Tuomilehto
Journal:  Drugs Aging       Date:  2000-07       Impact factor: 3.923

3.  "Stress" and lipids.

Authors:  A L Edwards
Journal:  CMAJ       Date:  1992-08-15       Impact factor: 8.262

4.  Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease.

Authors:  S R Majumdar; J H Gurwitz; S B Soumerai
Journal:  J Gen Intern Med       Date:  1999-12       Impact factor: 5.128

5.  The one-stop coronary cholesterol clinic: a multidisciplinary approach to implementing evidence-based treatment.

Authors:  P D Giles; S Ramachandran; A J Whitaker; A W Phillips; S J Fell; A Mitchell; T D Coleman
Journal:  Postgrad Med J       Date:  1996-12       Impact factor: 2.401

6.  Changes in serum lipid concentrations during first 24 hours after myocardial infarction.

Authors:  R Jackson; R Scragg; R Marshall; H White; K O'Brien; C Small
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-20

7.  Serum Lipid Profile: Fasting or Non-fasting?

Authors:  P K Nigam
Journal:  Indian J Clin Biochem       Date:  2010-12-29

Review 8.  Lipid Biomarkers for Risk Assessment in Acute Coronary Syndromes.

Authors:  Jeffrey W Meeusen; Leslie J Donato; Allan S Jaffe
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

9.  Elevated risk of myocardial infarction in very young immigrants from former Yugoslavia.

Authors:  Franz Wiesbauer; Hermann Blessberger; Georg Goliasch; Erik Walter Holy; Stephan Pfaffenberger; Ioannis Tentzeris; Gerald Maurer; Kurt Huber; Farshid Abdolvahab; Gottfried Sodeck; Markus Exner; Johann Wojta; Martin Schillinger
Journal:  Eur J Epidemiol       Date:  2009-09-26       Impact factor: 8.082

10.  Significance of small dense low-density lipoprotein as a risk factor for coronary artery disease and acute coronary syndrome.

Authors:  Sung Woo Kwon; Se-Jung Yoon; Tae Soo Kang; Hyuck Moon Kwon; Jeong-Ho Kim; Jihyuk Rhee; Sung-Ju Lee; Jong-Kwan Park; Jae Yun Lim; Young Won Yoon; Bum Kee Hong
Journal:  Yonsei Med J       Date:  2006-06-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.